Kit signal transduction - PubMed (original) (raw)
Review
Kit signal transduction
M L Taylor et al. Hematol Oncol Clin North Am. 2000 Jun.
Abstract
The current understanding of kit signaling is that a limited number of signaling proteins interact to build multiple interacting networks that allow diverse cellular responses. Cytoplasmic signaling proteins are increasingly seen to form networks directed through converging and interacting pathways rather than following a simple linear model. There are also numerous cross-connections between signaling proteins more distal to the receptor. Ras thus binds PI3 kinase and potentiates its activation, whereas the Rac-dependent protein kinase PAK phosphorylates MEK and thereby stabilizes its association with Raf. A signaling network with multiple intersecting pathways can obtain a single, coherent response from numerous, potentially conflicting signals. There is still limited information about the effect of activating mutations on various aspects of kit signaling. There is, however, mounting evidence that an activating mutation may enhance kit signaling and also induce factor-independent activation of kit. For instance, this activation could occur through degradation of SHP-1, the protein tyrosine phosphatase that negatively regulates kit signaling. There is also emerging evidence that inherent inhibitory factors may exist in the juxtamembrane of kit and may be suppressed as a result of a mutation in that region. Understanding the impact of these activating mutations on kit signaling is important, not only in contributing to the understanding of the pathogenesis of mastocytosis but ultimately in forming the basis for more effective therapeutic intervention in this disease.
Similar articles
- Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction.
Lennartsson J, Blume-Jensen P, Hermanson M, Pontén E, Carlberg M, Rönnstrand L. Lennartsson J, et al. Oncogene. 1999 Sep 30;18(40):5546-53. doi: 10.1038/sj.onc.1202929. Oncogene. 1999. PMID: 10523831 - Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor.
Roskoski R Jr. Roskoski R Jr. Biochem Biophys Res Commun. 2005 Nov 11;337(1):1-13. doi: 10.1016/j.bbrc.2005.08.055. Biochem Biophys Res Commun. 2005. PMID: 16129412 Review. - The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway.
Yu M, Luo J, Yang W, Wang Y, Mizuki M, Kanakura Y, Besmer P, Neel BG, Gu H. Yu M, et al. J Biol Chem. 2006 Sep 29;281(39):28615-26. doi: 10.1074/jbc.M603742200. Epub 2006 Jul 27. J Biol Chem. 2006. PMID: 16873377 - CSF-1 signal transduction.
Hamilton JA. Hamilton JA. J Leukoc Biol. 1997 Aug;62(2):145-55. doi: 10.1002/jlb.62.2.145. J Leukoc Biol. 1997. PMID: 9261328 Review. - c-Kit and c-kit mutations in mastocytosis and other hematological diseases.
Boissan M, Feger F, Guillosson JJ, Arock M. Boissan M, et al. J Leukoc Biol. 2000 Feb;67(2):135-48. doi: 10.1002/jlb.67.2.135. J Leukoc Biol. 2000. PMID: 10670573 Review.
Cited by
- An Innovative Model of ISS-Based Multiple Fractures and Gastrointestinal Dysfunction Related to c-Kit Protein Expression on Interstitial Cells of Cajal.
Meng SJ, Fan MQ, Qian JS, Zhang JW, Xu HH, Zheng Y, Zhao WQ, Shan LT, Huang JF. Meng SJ, et al. Orthop Surg. 2023 May;15(5):1325-1332. doi: 10.1111/os.13599. Epub 2023 Mar 15. Orthop Surg. 2023. PMID: 36919913 Free PMC article. - Analysis of clinicopathologic features and gene mutations in gastrointestinal stromal tumor: a series of 58 patients.
Cheng H, Qiu T, Shi SS. Cheng H, et al. Int J Clin Exp Pathol. 2021 Dec 15;14(12):1128-1137. eCollection 2021. Int J Clin Exp Pathol. 2021. PMID: 35027993 Free PMC article. - Effects of CO2 pneumoperitoneum on proliferation, apoptosis, and migration of gastrointestinal stromal tumor cells.
Zheng L, Zhou D, Lu L, Liu Z, Fang L. Zheng L, et al. Surg Endosc. 2019 Oct;33(10):3384-3395. doi: 10.1007/s00464-018-06633-6. Epub 2019 Jan 2. Surg Endosc. 2019. PMID: 30604263 - Combination of Luteolin and Solifenacin Improves Urinary Dysfunction Induced by Diabetic Cystopathy in Rats.
Xu J, Xu H, Yu Y, He Y, Liu Q, Yang B. Xu J, et al. Med Sci Monit. 2018 Mar 10;24:1441-1448. doi: 10.12659/msm.904534. Med Sci Monit. 2018. PMID: 29523776 Free PMC article. - Immunohistochemical study of C-kit expression in subtypes of renal cell carcinoma.
Norouzinia F, Abbasi F, Dindarian S, Mohammadi S, Meisami F, Bagheri M, Mohammadi H. Norouzinia F, et al. Turk J Urol. 2018 Jan;44(1):31-35. doi: 10.5152/tud.2018.91455. Epub 2018 Jan 8. Turk J Urol. 2018. PMID: 29484224 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous